MAPT and myeloid sarcoma: Significantly higher total tau concentration was measured in MS patients compared to controls (141.67 pg/mL, IQR 77.79–189.17, and 68.77 pg/mL, IQR 31.24–109.17, p = 0.025; Figure 1a).